{
  "chemotherapy": {
    "title": "Common Chemotherapy Drugs",
    "description": "Core cytotoxic agents used in leukemia and solid tumor regimens.",
    "drugs": [
      {
        "name": "Cyclophosphamide",
        "category": "Alkylating Agent",
        "route": "IV infusion",
        "keyPoints": [
          "Hydrate patient before and after administration.",
          "Monitor urine output; risk of hemorrhagic cystitis.",
          "Use mesna for uroprotection if ordered."
        ]
      },
      {
        "name": "Cytarabine (Ara-C)",
        "category": "Antimetabolite",
        "route": "IV infusion or subcutaneous",
        "keyPoints": [
          "Monitor for cerebellar toxicity—perform neuro checks.",
          "May cause conjunctivitis—use prophylactic steroid eye drops.",
          "High-dose regimens require leucovorin rescue."
        ]
      },
      {
        "name": "Doxorubicin",
        "category": "Anthracycline Antibiotic",
        "route": "IV push (central line preferred)",
        "keyPoints": [
          "Cardiotoxic—obtain baseline ECG and ejection fraction.",
          "Avoid extravasation; use vesicant precautions.",
          "Causes red discoloration of urine for 24–48 hrs."
        ]
      },
      {
        "name": "Vincristine",
        "category": "Vinca Alkaloid",
        "route": "IV push (never intrathecal!)",
        "keyPoints": [
          "Fatal if given intrathecally.",
          "Monitor for peripheral neuropathy and constipation.",
          "Use warm compresses if extravasation suspected."
        ]
      },
      {
        "name": "Methotrexate",
        "category": "Antimetabolite",
        "route": "IV, oral, or intrathecal",
        "keyPoints": [
          "Requires leucovorin (Calcium folinate) rescue for high doses.",
          "Monitor renal function and maintain hydration.",
          "Avoid NSAIDs and cotrimoxazole during therapy."
        ]
      }
    ]
  },

  "adjuvant": {
    "title": "Adjuvant / Supportive Medications",
    "description": "Medications used to prevent or manage chemotherapy-related toxicities.",
    "drugs": [
      {
        "name": "Ondansetron",
        "category": "Antiemetic",
        "route": "IV or oral",
        "keyPoints": [
          "Administer 30 minutes before chemotherapy.",
          "Monitor for headache and QT prolongation."
        ]
      },
      {
        "name": "Dexamethasone",
        "category": "Corticosteroid",
        "route": "IV or oral",
        "keyPoints": [
          "Used for nausea prevention and as part of chemotherapy regimens.",
          "Monitor blood sugar and signs of infection."
        ]
      },
      {
        "name": "Filgrastim (G-CSF)",
        "category": "Hematopoietic Growth Factor",
        "route": "Subcutaneous injection",
        "keyPoints": [
          "Monitor CBC; stop when ANC > 1000 in two consecutive days"
        ]
      },
      {
        "name": "Allopurinol",
        "category": "Uric Acid Reducer",
        "route": "Oral",
        "keyPoints": [
          "Start before induction chemotherapy to prevent tumor lysis.",
          "Encourage hydration and monitor uric acid levels."
        ]
      }
    ]
  }
}
